UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2528) 2528
Book Chapter (51) 51
Newspaper Article (20) 20
Conference Proceeding (3) 3
Magazine Article (3) 3
Book / eBook (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2376) 2376
science & technology (1869) 1869
life sciences & biomedicine (1779) 1779
male (1365) 1365
female (1197) 1197
middle aged (1066) 1066
aged (975) 975
bile duct neoplasms - drug therapy (831) 831
bile duct neoplasms - pathology (752) 752
oncology (735) 735
cholangiocarcinoma (680) 680
adult (628) 628
cholangiocarcinoma - drug therapy (615) 615
cholangiocarcinoma - pathology (611) 611
gastroenterology & hepatology (543) 543
cancer (515) 515
surgery (467) 467
bile ducts, intrahepatic (438) 438
animals (433) 433
treatment outcome (399) 399
chemotherapy (364) 364
cell line, tumor (350) 350
bile ducts, intrahepatic - pathology (345) 345
prognosis (337) 337
aged, 80 and over (335) 335
bile duct neoplasms - surgery (331) 331
bile duct neoplasms - metabolism (298) 298
bile (285) 285
cholangiocarcinoma - metabolism (282) 282
retrospective studies (274) 274
antineoplastic combined chemotherapy protocols - therapeutic use (267) 267
bile duct neoplasms - mortality (257) 257
deoxycytidine - analogs & derivatives (257) 257
medicine & public health (256) 256
tumors (249) 249
cholangiocarcinoma - genetics (247) 247
liver (247) 247
bile duct neoplasms - genetics (245) 245
bile duct neoplasms - therapy (245) 245
abridged index medicus (216) 216
analysis (214) 214
cholangiocarcinoma - mortality (213) 213
mice (211) 211
cholangiocarcinoma - surgery (208) 208
bile duct neoplasms - diagnosis (202) 202
liver neoplasms - drug therapy (201) 201
risk factors (200) 200
metastasis (196) 196
neoplasm staging (191) 191
apoptosis (188) 188
liver cancer (188) 188
health aspects (185) 185
cholangiocarcinoma - therapy (184) 184
combined modality therapy (180) 180
survival rate (179) 179
patients (174) 174
antineoplastic agents - therapeutic use (171) 171
medical prognosis (169) 169
research (168) 168
cholangiocarcinoma - diagnosis (156) 156
fluorouracil - administration & dosage (156) 156
cancer therapies (154) 154
care and treatment (153) 153
follow-up studies (152) 152
apoptosis - drug effects (150) 150
gastroenterology (148) 148
liver neoplasms - pathology (148) 148
immunohistochemistry (146) 146
cell proliferation - drug effects (142) 142
deoxycytidine - administration & dosage (138) 138
gastroenterology and hepatology (137) 137
pathology (135) 135
survival analysis (135) 135
proteins (134) 134
gemcitabine (130) 130
adenocarcinoma - drug therapy (129) 129
gene expression (129) 129
chemotherapy, adjuvant (128) 128
bile duct (127) 127
tomography, x-ray computed (127) 127
research article (120) 120
medicine (118) 118
time factors (118) 118
liver neoplasms - secondary (116) 116
mice, nude (115) 115
common bile duct neoplasms - surgery (114) 114
radiology, nuclear medicine & medical imaging (114) 114
studies (113) 113
pharmacology & pharmacy (112) 112
bile duct neoplasms - complications (111) 111
disease-free survival (111) 111
gene expression regulation, neoplastic (110) 110
rodents (110) 110
cell proliferation (109) 109
common bile duct neoplasms - drug therapy (109) 109
stents (108) 108
kaplan-meier estimate (107) 107
mutation (107) 107
gallbladder neoplasms - drug therapy (106) 106
intrahepatic cholangiocarcinoma (106) 106
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2426) 2426
Japanese (161) 161
German (32) 32
French (21) 21
Spanish (14) 14
Italian (10) 10
Russian (9) 9
Chinese (7) 7
Portuguese (5) 5
Danish (4) 4
Polish (4) 4
Korean (3) 3
Czech (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 10/2002, Volume 95, Issue 8, pp. 1685 - 1695
Journal Article
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 1 - 10
.... Results Forty-one patients with advanced solid tumours refractory to standard therapies and with adequate organ function were recruited in eight cohorts up to doses of 150... 
Hematology, Oncology and Palliative Medicine | Pharmacodynamics | MEK inhibitor | Phase I | Optimal biological dose | Pharmacokinetics | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Pancreatic Neoplasms - metabolism | Nausea - chemically induced | Allosteric Regulation | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Fatigue - chemically induced | Ribosomal Protein S6 Kinases, 70-kDa - drug effects | Protein Kinase Inhibitors - adverse effects | Colorectal Neoplasms - drug therapy | Chromatography, Liquid | Proto-Oncogene Proteins c-akt - metabolism | MAP Kinase Kinase 1 - antagonists & inhibitors | Bile Duct Neoplasms - metabolism | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Administration, Oral | Carcinoma, Non-Small-Cell Lung - metabolism | Neoplasms - drug therapy | Maximum Tolerated Dose | Mesothelioma - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Anorexia - chemically induced | Glycogen Synthase Kinase 3 beta - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Neoplasms - metabolism | Phosphoproteins - drug effects | Mitogen-Activated Protein Kinase 1 - drug effects | Cholangiocarcinoma - metabolism | Chromatography, High Pressure Liquid | Diarrhea - chemically induced | Mitogen-Activated Protein Kinase 3 - drug effects | Pancreatic Neoplasms - drug therapy | Tandem Mass Spectrometry | Uterine Cervical Neoplasms - metabolism | Esophageal Neoplasms - metabolism | Adult | Female | Colorectal Neoplasms - metabolism | Bile Duct Neoplasms - drug therapy | Drug Eruptions - etiology | Abdominal Pain - chemically induced | Uterine Cervical Neoplasms - drug therapy | Glycogen Synthase Kinase 3 beta - metabolism | Mesothelioma - drug therapy | Cholangiocarcinoma - drug therapy | MAP Kinase Kinase 2 - antagonists & inhibitors | Protein Kinase Inhibitors - therapeutic use | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Esophageal Neoplasms - drug therapy | Proto-Oncogene Proteins c-akt - drug effects | Care and treatment | Protein kinases | Mitogens | Cells | Tumors | Index Medicus
Journal Article
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 05/2016, Volume 13, Issue 5, pp. 261 - 280
Journal Article
Journal of immunology research, ISSN 2314-7156, 2014, Volume 2014, pp. 1 - 19
..., increased proliferation rate, and angiogenesis. Furthermore, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to decrease incidence and mortality... 
Life Sciences & Biomedicine | Immunology | Science & Technology | Tumor Necrosis Factor-alpha - metabolism | Inflammation - pathology | Oxidative Stress | Colitis - genetics | Colorectal Neoplasms - genetics | Humans | Tumor Necrosis Factor-alpha - genetics | Colitis - complications | Colitis - pathology | Cholangiocarcinoma - metabolism | Inflammation - complications | Colorectal Neoplasms - etiology | Inflammation - metabolism | Bile Ducts, Intrahepatic - metabolism | Tumor Microenvironment - genetics | Interleukin-10 - metabolism | Bile Duct Neoplasms - genetics | Interleukin-6 - metabolism | Colorectal Neoplasms - metabolism | Bile Ducts, Intrahepatic - pathology | Gene Expression | Bile Duct Neoplasms - metabolism | Interleukin-6 - genetics | Carcinogenesis - genetics | Cholangiocarcinoma - pathology | Transforming Growth Factor beta - genetics | Interleukin-10 - genetics | Colitis - metabolism | Cholangiocarcinoma - genetics | Inflammation - genetics | Bile Duct Neoplasms - pathology | Colorectal Neoplasms - pathology | Chronic Disease | Transforming Growth Factor beta - metabolism | Free radicals | Cytokines | Disease | Mortality | Clinical trials | Metastasis | Cancer therapies | Proteins | Angiogenesis | Medical prognosis | Tumorigenesis | Nonsteroidal anti-inflammatory drugs | Chemokines | Immune system | Tumors | Cancer | Apoptosis | Index Medicus | Review
Journal Article
PLoS genetics, ISSN 1553-7404, 02/2014, Volume 10, Issue 2, pp. e1004135 - e1004135
.... New advances in drug treatment have enabled treatment of these cancers with "targeted therapy" that exploits an error in the normal functioning of a tumor cell, compared to other cells in the body... 
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Prognosis | Receptor, Fibroblast Growth Factor, Type 2 - metabolism | Humans | Transcriptome | Imidazoles - administration & dosage | Molecular Targeted Therapy | Receptor, Epidermal Growth Factor - metabolism | Pyridazines - administration & dosage | Quinazolines - administration & dosage | Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors | Bile Duct Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Bile Ducts, Intrahepatic - pathology | Pyrimidines - administration & dosage | Signal Transduction - genetics | Cholangiocarcinoma - pathology | Protein Kinase Inhibitors | Cholangiocarcinoma - drug therapy | Cell Line, Tumor | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Bile Duct Neoplasms - pathology | Mutation | Genome, Human | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Sulfonamides - administration & dosage | Antimitotic agents | Analysis | Genomics | Research | Antineoplastic agents | Health aspects | Tumors | Index Medicus | Studies | Hepatitis | Substance abuse treatment | Genetic engineering | Genomes | Kinases | Gene expression | Patients | Cancer
Journal Article